Ommaviy ro‘yxatga olingan 180 Life Sciences ETH xazinasini tashkil etish uchun 425 million dollarlik xususiy joylashtirishni rejalashtirmoqda

ChainCatcher ma’lumotlariga ko‘ra, PR Newswire xabarida aytilishicha, Nasdaq’da ro‘yxatdan o‘tgan 180 Life Sciences kompaniyasi xususiy kapital moliyalashtirish orqali taxminan 425 million dollar yig‘ishni rejalashtirmoqda. Yig‘ilgan mablag‘lar Ethereum xazinasini tashkil etish uchun ishlatiladi va bitim yakunlangach, kompaniya ETHZilla Corporation nomiga o‘zgartiriladi.

Ma’lum qilinishicha, ushbu bitimda ishtirok etayotgan investorlar qatorida Harbour Island, Electric Capital, Polychain Capital, GSR, Omicron Technologies, Konstantin Lomashuk (Lido va p2p.org hammuassisi), Sreeram Kannan (Eigenlayer asoschisi), Mike Silagadze (Ether.fi asoschisi), Danny Ryan (Etherealize hammuassisi), Vivek Raman (Etherealize hammuassisi), Sam Kazemanian (Frax hammuassisi), Grant Hummer (Etherealize hammuassisi), Robert Leshner (Compound va Superstate asoschisi), Tarun Chitra (Gauntlet asoschisi) va boshqalar bor.